Impact of neonatal hypoxia‐ischaemia on oligodendrocyte survival, maturation and myelinating potential

Małgorzata Ziemka‐Nałęcz(Mossakowski Medical Research Institute, Polish Academy of Sciences), Joanna Sypecka(Mossakowski Medical Research Institute, Polish Academy of Sciences), Justyna Janowska(Mossakowski Medical Research Institute, Polish Academy of Sciences), Małgorzata Frontczak‐Baniewicz(Mossakowski Medical Research Institute, Polish Academy of Sciences), Lukasz Strojek(Mossakowski Medical Research Institute, Polish Academy of Sciences), Teresa Zalewska(Mossakowski Medical Research Institute, Polish Academy of Sciences), Joanna Jaworska(InLife Institute of Animal Reproduction and Food Research, Polish Academy of Sciences)
Journal of Cellular and Molecular Medicine
August 7, 2017
10.1111/jcmm.13309
Cited by 38

Related Papers

The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders
|Cells|2020|273
The potential neuroprotective role of a histone deacetylase inhibitor, sodium butyrate, after neonatal hypoxia-ischemia
|Journal of Neuroinflammation|2017|107
Insights Into the Neuroinflammatory Responses After Neonatal Hypoxia-Ischemia
|Journal of Neuropathology & Experimental Neurology|2017|104
Effect of the HDAC Inhibitor, Sodium Butyrate, on Neurogenesis in a Rat Model of Neonatal Hypoxia–Ischemia: Potential Mechanism of Action
|Molecular Neurobiology|2019|94
Sodium Butyrate, a Histone Deacetylase Inhibitor, Exhibits Neuroprotective/Neurogenic Effects in a Rat Model of Neonatal Hypoxia-Ischemia
|Molecular Neurobiology|2016|74